Ee HC - Search Results

1

Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.

Daveson AJM, Ee HC, Andrews JM, King T, Goldstein KE, Dzuris JL, MacDougall JA, Williams LJ, Treohan A, Cooreman MP, Anderson RP. Daveson AJM, et al. Among authors: ee hc. EBioMedicine. 2017 Dec;26:78-90. doi: 10.1016/j.ebiom.2017.11.018. Epub 2017 Nov 22. EBioMedicine. 2017. PMID: 29191561 Free PMC article. Clinical Trial.

2

Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease.

Truitt KE, Daveson AJM, Ee HC, Goel G, MacDougall J, Neff K, Anderson RP. Truitt KE, et al. Among authors: ee hc. Aliment Pharmacol Ther. 2019 Sep;50(5):547-555. doi: 10.1111/apt.15435. Epub 2019 Aug 13. Aliment Pharmacol Ther. 2019. PMID: 31407810 Clinical Trial.

3

Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease.

Tye-Din JA, Daveson AJM, Goldstein KE, Hand HL, Neff KM, Goel G, Williams LJ, Truitt KE, Anderson RP; RESET CeD Study Group. Tye-Din JA, et al. BMC Med. 2020 Nov 26;18(1):362. doi: 10.1186/s12916-020-01828-y. BMC Med. 2020. PMID: 33239013 Free PMC article.

4

Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease.

Tye-Din JA, Daveson AJM, Ee HC, Goel G, MacDougall J, Acaster S, Goldstein KE, Dzuris JL, Neff KM, Truitt KE, Anderson RP. Tye-Din JA, et al. Among authors: ee hc. Aliment Pharmacol Ther. 2019 Oct;50(8):901-910. doi: 10.1111/apt.15477. Epub 2019 Sep 4. Aliment Pharmacol Ther. 2019. PMID: 31483515 Clinical Trial.

5

Gastric intraepithelial neoplasia in a Western population.

Raftopoulos SC, Kumarasinghe P, de Boer B, Iacobelli J, Kontorinis N, Fermoyle S, Olynyk J, Forrest C, Ee HC, Yusoff IF. Raftopoulos SC, et al. Among authors: ee hc. Eur J Gastroenterol Hepatol. 2012 Jan;24(1):48-54. doi: 10.1097/MEG.0b013e32834dc1bb. Eur J Gastroenterol Hepatol. 2012. PMID: 22081007

6

Outcomes of endoscopic resection of large colorectal neoplasms: an Australian experience.

Salama M, Ormonde D, Quach T, Ee H, Yusoff I. Salama M, et al. J Gastroenterol Hepatol. 2010 Jan;25(1):84-9. doi: 10.1111/j.1440-1746.2009.05987.x. Epub 2009 Sep 27. J Gastroenterol Hepatol. 2010. PMID: 19793173

7

Familial and non-familial risk factors associated with colorectal cancer survival in young and middle-aged patients.

Kelty E, Ward SV, Cadby G, McCarthy NS, O'Leary P, Moses EK, Ee HC, Preen DB. Kelty E, et al. Among authors: ee hc. Int J Colorectal Dis. 2019 Oct;34(10):1673-1680. doi: 10.1007/s00384-019-03380-5. Epub 2019 Aug 30. Int J Colorectal Dis. 2019. PMID: 31471697

8

A cohort study of missed and new cancers after esophagogastroduodenoscopy.

Raftopoulos SC, Segarajasingam DS, Burke V, Ee HC, Yusoff IF. Raftopoulos SC, et al. Among authors: ee hc. Am J Gastroenterol. 2010 Jun;105(6):1292-7. doi: 10.1038/ajg.2009.736. Epub 2010 Jan 12. Am J Gastroenterol. 2010. PMID: 20068557

9

The issue is tissue.

Subramaniam K, Ee HC, Fermoyle S, Siah CW. Subramaniam K, et al. Among authors: ee hc. Gut. 2011 Mar;60(3):298, 324. doi: 10.1136/gut.2010.215277. Epub 2010 Sep 28. Gut. 2011. PMID: 21296789 No abstract available.

10

Making sense of differing bowel cancer screening guidelines.

Ee HC, Olynyk JK. Ee HC, et al. Med J Aust. 2009 Apr 6;190(7):348-9. doi: 10.5694/j.1326-5377.2009.tb02444.x. Med J Aust. 2009. PMID: 19351305 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters